Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues medicine CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would consider new talks with insurers regarding the listing prices of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. Hear the https://busch-light-peach-nutriti27271.csublogs.com/37132051/the-2-minute-rule-for-healthcare-news